Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.
Signaling output of bone morphogenetic proteins (BMPs) is determined by two sets of opposing interactions, one with heterotetrameric complexes of cell surface receptors, the other with secreted antagonists that act as ligand traps. We identified two mutations (N445K,T) in patients with multiple syno...
Main Authors: | Petra Seemann, Anja Brehm, Jana König, Carsten Reissner, Sigmar Stricker, Pia Kuss, Julia Haupt, Stephanie Renninger, Joachim Nickel, Walter Sebald, Jay C Groppe, Frank Plöger, Jens Pohl, Mareen Schmidt-von Kegler, Maria Walther, Ingmar Gassner, Cristina Rusu, Andreas R Janecke, Katarina Dathe, Stefan Mundlos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC2776984?pdf=render |
Similar Items
-
A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.
by: Elisa Degenkolbe, et al.
Published: (2013-01-01) -
Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance.
by: Julia Zimmer, et al.
Published: (2012-01-01) -
Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics
by: D Wulsten, et al.
Published: (2011-02-01) -
Noggin as a regulator of bone remodelling
by: Fatemeh Safari, et al.
Published: (2020-10-01) -
Noggin's role in obesity: Biomarker potential?
by: Maria Luz Gunturiz Albarracín
Published: (2020-12-01)